Outcomes of Patients With Solid Tumor Treated on Phase I Clinical Trials Within a Comprehensive Cancer Center's Private and Safety-Net Hospitals
Enrollment of patients into early-phase clinical trials for solid tumors is challenging, but it is feasible to enroll patients both in a private hospital setting and in a safety-net hospital. Patient outcomes are similar regardless of enrollment site, and racial/ethnic diversity is increased compared with historic national averages in the United States.
Authors
- Anthony B. El-Khoueiry (ORCID: https://orcid.org/0000-0002-9053-3841)
- Jacob Thomas (ORCID: https://orcid.org/0000-0002-8420-366X)
- Rebecca Umayam
- Emmeline Friedman (ORCID: https://orcid.org/0000-0003-0934-1074)
- Gage Guerra (ORCID: https://orcid.org/0009-0009-2508-4953)
- Hadi Erfani (ORCID: https://orcid.org/0000-0002-1655-6877)
- Xiomara Casal Menéndez
- Varsha Tulpule (ORCID: https://orcid.org/0000-0003-3449-7572)
- Loh Kwok Seng
- Sabrina Woll (ORCID: https://orcid.org/0009-0003-3627-648X)
- Austin Luong
- Jessica Levano
- Diana L. Hanna (ORCID: https://orcid.org/0000-0003-2681-5032)
- Anastasia Martynova
Institutions
- University of Southern California (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1200/op-25-00542
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00